Showing results (241-250 of 264) with videos related to
Sort By:
Pageof 27
Digestion|January 1, 1990
Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in manW E Schmidt, W Creutzfeldt, M Höcker, et al.The American Journal of Physiology|February 1, 1991
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumideW E Schmidt, W Creutzfeldt, A Schleser, et al.Gastroenterology|December 1, 1993
Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogsP Hoffmann, G A Eberlein, J R Reeve, et al.Digestion|January 1, 1991
Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassayJ Mössner, J M Zeeh, G Eberlein, et al.Gastroenterology|May 1, 1997
Altered postprandial motility in chronic pancreatitis: role of malabsorptionP Layer, M R von der Ohe, J J Holst, et al.Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.Alimentary Pharmacology & Therapeutics|January 23, 2008
Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxietyS Haag, W Senf, W Häuser, et al.Gut|January 13, 2006
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitisT Kühbacher, S J Ott, U Helwig, et al.Pancreas|July 1, 1996
Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptorsS Teyssen, D Grandt, E Niebergall-Roth, et al.The American Journal of Physiology|June 11, 1990
Molecular variants of cholecystokinin after endogenous stimulation in humans: a time studyV E Eysselein, G A Eberlein, W H Hesse, et al.Pageof 27